Normalized activated protein C ratio itself not associated with increased risk of venous thromboembolism

Contraception

Volumn 58, Issue 5, 1998, Pages 321-322

  Heinemann, L A J ^a   Assmann, A ^a   Spannagl, M ^b   Schramm, W ^b   Dick, A ^b   Kluft, C ^c   De Maat, M P M ^c  

^a ZEG Ctr Epidemiol and Hlth Res   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c TNO   (Netherlands)

Author keywords

Factor V Leiden mutation; Normalized activated protein C ratio; Tissue factor initiated test

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5 LEIDEN; ORAL CONTRACEPTIVE AGENT; THROMBIN; THROMBOPLASTIN;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; VEIN THROMBOSIS;

BIOLOGY; BLOOD PROTEINS; CASE CONTROL STUDIES; CONTRACEPTION; CONTRACEPTIVE METHODS--PHARMACODYNAMICS; DEVELOPED COUNTRIES; DISEASES; EMBOLISM; EUROPE; FAMILY PLANNING; GERMANY; HEMIC SYSTEM; ORAL CONTRACEPTIVES, COMBINED--PHARMACODYNAMICS; ORAL CONTRACEPTIVES--PHARMACODYNAMICS; PHYSIOLOGY; RESEARCH METHODOLOGY; RESEARCH REPORT; RISK FACTORS; STUDIES; THROMBOEMBOLISM; VASCULAR DISEASES; WESTERN EUROPE;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL; FACTOR V; FEMALE; HUMANS; MIDDLE AGED; MUTATION; ODDS RATIO; PROTEIN C; REGRESSION ANALYSIS; RISK FACTORS; VENOUS THROMBOSIS;

EID: 0032430581     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(98)00111-5     Document Type: Article

References (2)

1. Rosing J., Tang G., Nicolaes G.A.F., et al. Oral contraceptives and venous thrombosis different sensitivities to activated protein C in women using second- and third-generation oral contraceptives . Br J Haematol. 97:1997;23-38.
2. Schramm W., Heinemann L.A. Oral contraceptives and venous thromboembolism acquired APC resistance? Br J Haematol. 98:1997;491-492.